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Background: Although prenatal and postnatal programming of metabolic diseases in 
adulthood is well established, the mechanisms underpinning metabolic programming 
are not. Dlk1, a key regulator of fetal development, inhibits adipocyte differentiation 
and restricts fetal growth.  
Methods: Assess DLk1 expression in a Wistar rat model of catch-up growth following 
intrauterine restriction. Dams fed ad libitum delivered control pups (C) and dams on a 
50% calorie-restricted diet delivered pups with low birth weight (R). Restricted 
offspring fed a standard rat chow showed catch-up growth (R/C) but those kept on a 
calorie-restricted diet did not (R/R).  
Results: Decreased Dlk1 expression was observed in adipose tissue and skeletal muscle 
of R/C pups along with excessive visceral fat accumulation, decreased circulating 
adiponectin, increased triglycerides and HOMA-IR (from p<0.05 to p<0.0001). 
Moreover, in R/C pups the reduced Dlk1 expression in adipose tissue and skeletal 
muscle correlated with visceral fat (r= −0.820, p<00001) and HOMA-IR (r= −0.745, 
p=0.002). 
Conclusions: Decreased Dlk1 expression relates to visceral fat expansion and insulin 
resistance in a rat model of catch-up growth following prenatal growth restriction. 
Modulation of Dlk1 expression could be among the targets for the early prevention of 
fetal programming of adult metabolic disorders.  




Fetal programming is a process by which the fetus’ adaptations to the adverse 
conditions during gestation and early postnatal life have long-term effects on the 
newborn (1). Clinical studies, and subsequent work in animal models, have 
demonstrated that adverse conditions in these critical developmental windows can 
program physiological processes and cause metabolic alterations leading to future 
adult diseases, such as obesity, type 2 diabetes, metabolic syndrome and 
cardiovascular disease (1),(2),(3).  
Fetal development is sensitive to the nutritional environment. Adaptations to adverse 
conditions serve to optimize and improve the chances of fetal survival. However, when 
there is a mismatch between fetal and postnatal nutrition, this adapted thrifty 
phenotype is inappropriate, becomes detrimental and contributes to metabolic 
disorders in adulthood (3),(4). Consequently, the major risk of developing these 
disorders later in life has been associated with postnatal catch-up growth following 
low birth weight, a condition occurring in approximately 8% of pregnancies worldwide 
(1),(2),(5). 
The impact of early life insults on childhood and adult health is certainly apparent; 
however, the mechanisms underlying the alterations in metabolic programming 
remain largely unknown. The study of genes that regulate fat storage, whose 
alterations lead to insulin resistance, are of central importance for understanding the 
pathophysiology of catch-up growth.  
Delta-like protein 1 (Dlk1) gene is a key regulator of fetal development and it is 
involved in energy and nutrient metabolism. In adults, its expression is limited to 
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endocrine tissues: Dlk1 inhibits adipocyte differentiation in adipose tissue and is 
involved in regeneration processes in skeletal muscle (6),(7),(8). Our group has 
previously linked prenatal and postnatal growth with the placental imprinted DLK1-
DIO3 domain in human studies (9); others have described that impairments in fetally 
derived DLK1 cause fetal growth restriction (10). Studies, however, linking Dlk1 gene 
expression and catch-up growth following prenatal restriction are lacking. 
The aim of the study was to assess whether changes in Dlk1 gene expression relate to 
metabolic risk markers in an animal model of postnatal catch-up growth following fetal 
weight restriction. 
Methods 
Rat model of catch-up growth following prenatal growth restriction 
A Wistar rat model of intrauterine growth restriction induced by calorie restriction 
throughout gestation was used. Studies were approved by the Animal Research Ethic 
Committee (C.E.E.A., #DAAM 6911) of the University of Barcelona and were in 
accordance with the Catalan Government guideline 214/97. First-time-pregnant Wistar 
rats (Janvier, Le Genest Saint Isle, France) were housed in a facility with constant 
temperature (21 ± 1ºC) and humidity (50-60%) and a controlled 12:12-h light-dark 
cycle. The first day of gestation was determined by observation of spermatozoa in 
vaginal smears. From day 1 of pregnancy to term, control dams (C) were provided an 
ad libitum diet consisting of a standard laboratory chow (Teklad Global Rodent 
Maintenance Diet, Harlan Laboratories Inc.; 14% protein, 4% fat, 2900 kcal/kg) and 
restricted dams (R) were fed a 50% less of diet used in control dams (Supplementary 
Figure S1). Rat dams gave birth normally and pups were limited to ten per litter at day 
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1 after birth to normalize pups feeding. Throughout the 21-day lactation period, 
different control or restricted diets were provided in order to create 3 experimental  
groups: control dams were fed an ad libitum diet (C/C) and restricted dams were fed 
either an ad libitum diet (R/C) or a restricted diet (R/R) to create catch-up or non-
catch-up growth groups, respectively (Supplementary Figure S1). At 22-days of age, 
after the lactation period, offspring in all groups were weaned to ad libitum feed. All  
pups were weighed twice a week from postnatal day 1 (PD1) until PD42. At PD42 all 
pups (N=14 per group; 7 females and 7 males) fasted overnight were anesthetized with 
3% isoflurane and euthanized by cardiac exsanguination. Blood was collected via 
cardiac puncture in heparinized syringes and centrifuged at 3500 rpm for 15 minutes 
at 4ºC to obtain plasma samples which were stored at -80ºC. Adipose tissue from 
different locations in the abdomen and skeletal gastrocnemius muscle samples were 
immediately frozen in liquid nitrogen. Additionally, an approximation to body 
composition was obtained by calculating visceral fat tissue mass (sum of weights of 
perigonadal, retroperitoneal and mesenteric adipose tissues). For gene and protein 
expression studies, rat retroperitoneal adipose tissue was selected as being equivalent 
to human omental adipose tissue. 
Plasma metabolic profile 
Plasma adiponectin and insulin concentrations were determined by ELISA using a 
commercial kit (Rat Adiponectin ELISA Kit, and Ultrasensitive Rat Insulin ELISA kit; 
Crystal Chem Inc.). For adiponectin, the sensitivity of the kit was 0.25 mg/l and intra-
assay CVs were less than 10% and for insulin, the sensitivity was 0.1 ng/ml and intra-
assay CVs were less than 10%. Plasma glucose, total cholesterol, HDL-cholesterol and 
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triglycerides were determined by dry chemistry technique (Spotchem II, Spotchem EZ 
SP-4410, Menarini Diagnostics-Akray, Japan). Homeostatic model assessment of insulin 
resistance (HOMA-IR) was assessed using the following formula: 
HOMA-IR index=glucose*insulin/2430 (11). 
Gene and protein expression 
For gene expression, RNA (RNAeasy mini kit, Qiagen) was extracted and 2 µg of total  
RNA was retro-transcribed to cDNA (High-capacity cDNA Reverse Transcription Kit, 
Applied Biosystems, Thermo Fisher Scientific Inc.). cDNA samples were used to 
quantify the relative expression by real-time PCR (Taqman Assays 20X [Dlk1: 
Rn00587011_m1 and endogenous control GAPDH:  Rn01775763_g1], Applied 
Biosystems, Thermo Fisher Scientific Inc.). For protein quantification, total protein was 
extracted from tissue (DC protein assay, Bio-Rad Laboratories Inc.). Total protein 
concentration was quantified by the Lowry method and Dlk1 protein concentrations by 
an ELISA commercial kit (Rat Delta Like 1 Homolog Dlk1 ELISA kit, MyBioSource, Inc.). 
The sensitivity of the kit was 0.27 ng/ml and intra-assay CVs were less than 9%. 
Tissue morphology 
For morphometric studies, retroperitoneal adipose tissue from the abdominal cavity 
and skeletal gastrocnemius muscle from a set of 12 animals (N=4 animals per each 
treatment, 2 males and 2 females) were used. Tissues were paraffin-embedded, tissue 
sections were deparaffinized by the xylene-ethanol sequence and processed using the 
hematoxilin-eosin dye method. Images were taken at 200X (Olympus BX51, XC50 
CellVe). One histological section of each animal was randomly selected from the 
histological slides. Twelve randomly chosen fields per section were considered for the 
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measurement of both adipocyte area and density (more than 250 adipocytes were 
analyzed per group) and skeletal muscle cross-sectional myofiber density and cross-
sectional myofiber area. The measurements were analyzed in a blinded manner and 
both manual and automatic tools of the Image J software (NIH, public domain) were 
used. 
Statistical analysis 
All statistics were performed with SPSS 22.0 (SPSS software, IBM, Inc.) and graphs 
were done with Prism 6.0 (GraphPad Software, Inc.). Differences between 
experimental groups were compared using ANOVA test and least significance 
difference (LSD) post hoc tests. Spearman correlation was used to analyze associations 
between variables. Combined data for males and females are shown, since no sex 
differences were evident. Data are expressed as mean ± standard deviation (SD) and p 
value was set at 0.05. 
Results 
Catch-up growth Wistar rats following prenatal growth restriction exhibited increased 
fat mass and higher HOMA-IR  
At birth, R/R and R/C pups showed less body weight (p<0.0001, Table 1) relative to C/C 
pups: both R/R and R/C pups showed a 22% lower value in body weight at birth in 
relation to C/C pups. At weaning (PD22), R/C pups showed higher body weight 
(p<0.0001; Table 1) and at PD42 these pups experienced further postnatal weight gain 
(p<0.0001; Table 1), together with higher retroperitoneal adipose tissue weight and 
higher visceral fat (from p<0.05 to p<0.0001; Table 1), as compared to other pup 
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groups. At PD42, R/C pups showed also lower total adiponectin, higher plasma 
triglycerides (both p<0.01; Table 1) and higher insulin concentration and HOMA-IR 
index (both p<0.0001; Table 1), as compared to R/R pups.   
Decreased Dlk1 expression in adipose tissue and skeletal muscle relates to visceral fat 
and HOMA-IR in catch-up growth Wistar rats following prenatal growth restriction. 
Relative Dlk1 expression in R/C pups was decreased in both retroperitoneal adipose 
tissue and skeletal muscle compared to R/R pups (p<0.0001; Table 1). Likewise, Dlk1 
protein concentrations in retroperitoneal adipose tissue were lower in R/C pups 
(p<0.001; Table 1) compared to other pup groups. In adipose tissue, negative 
correlations between Dlk1 relative expression and body weight, postnatal body weight 
gain and visceral fat at PD42 were observed (all between r= -0.820 and r= -0.895, 
p<0.0001; Figure 1 and Supplementary Table S1). In muscle, negative correlations 
between Dlk1 relative expression and plasma insulin and HOMA-IR index were 
observed (r= -0.701, p=0.005 and r= -0.745, p=0.002; respectively; Figure 1 and 
Supplementary Table S1). 
Catch-up growth Wistar rats following prenatal growth restriction showed 
hypertrophied adipocytes and enlarged skeletal muscle myofibers 
The histological studies showed higher adipocyte area (4933 μm2± 1336; 3277 μm2 ± 
900; 2144 μm2 ± 533; p<0.0001) and lower adipocyte density (242 nº/mm2 ± 85; 340 
nº/mm2 ± 83; 531 nº/mm2 ± 153; p<0.0001) in retroperitoneal adipose tissue and 
lower density or number of myofibers per area (491 nº/nm2 ± 90; 474 nº/nm2 ± 45; 
726 nº/nm2 ± 95; p=0.003) in skeletal muscle of R/C pups, as compared to C/C and R/R 
groups, respectively (Figure 2). 




In the present model of catch-up growth following fetal growth restriction, we 
observed decreased Dlk1 in both visceral fat and skeletal muscle in pups experiencing 
catch-up growth. Moreover, in these pups, reduced Dlk1 gene expression in 
retroperitoneal adipose tissue was related to visceral fat mass accumulation, and 
reduced Dlk1 gene expression in skeletal muscle was associated with insulin 
resistance.  
As expected, in our experimental model of catch-up growth following fetal weight 
restriction, R/C pups successfully presented catch-up growth, as judged by higher body 
weight gain and visceral adiposity at P42. Previous studies have shown excessive 
visceral fat accumulation during catch-up growth (12). It has also been suggested that 
permanent changes in the expression of regulatory proteins in liver, muscle and 
adipose during catch-up growth relate to insulin resistance and metabolic disorders 
later in life (4). In our study, R/C pups showed not only increased visceral fat but also 
decreased circulating adiponectin and increased plasma triglycerides. It is well known 
that circulating adiponectin concentrations decrease along with visceral fat 
accumulation (13). Consequently, the observed visceral fat mass accumulation, low 
adiponectin levels and high triglycerides during catch-up growth may reflect 
dysregulation of adipose tissue function, which may plausibly contribute to the 
development of insulin resistance in these animals. This is substantiated by previous 
studies relating catch-up growth and insulin resistance in Wistar rats (14) and by our 
results showing higher HOMA-IR values in R/C pups. Catch-up growth in these pups 
caused both visceral fat accumulation and insulin resistance as early as at postnatal 
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period PD42. On the contrary, R/R pups kept postnatally under restricted conditions, in 
order to prevent the mismatch between fetal and postnatal nutrition, exhibited rather 
insulin sensitivity. Metabolic programming has been described to present both altered 
fat expansion and disrupted insulin signaling pathway leading to insulin resistance, 
although the molecular mechanisms implicated in these processes are not fully 
understood. 
Dlk1 is a regulator of adipocyte differentiation and adipogenesis (6),(15). The decrease 
in Dlk1 relative gene expression and Dlk1 protein concentrations in retroperitoneal 
adipose tissue at P42 together with the negative correlations between Dlk1 expression 
and body weight, body weight gain and visceral fat mass in R/C pups point to a 
relevant role of Dlk1 in the control of adipocyte growth and differentiation during 
catch-up growth. It was shown that mice with Dlk1 deficiency presented higher 
amounts of visceral fat, circulating lipids and adipocyte cell size at weaning and 
developed obesity and fatty liver disease (6),(16),(8). Histologically, hypertrophied 
adipocytes have been consistently found in adipose tissue of individuals with obesity 
(17) as well as in restricted pups at weaning (12),(18),(19). This observation has been 
related to a lower number of progenitor adipocytes capable of differentiating into 
healthy adipocytes (20). Accordingly, our results showed hypertrophy of the 
retroperitoneal adipose tissue in R/C pups at P42, which was characterized by higher 
adipocyte area and lower adipocyte density. The low Dlk1 expression observed in R/C 
pups may thus predispose these pups to postnatal adipose tissue expansion, especially 
of visceral fat, with a low number of preadipocytes being capable of differentiating  
into mature adipocytes, in turn contributing to adipocyte dysfunction. Indeed, low 
Dlk1 gene expression in adipose tissue is likely to cause excessive adipocyte lipid 
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storage, inflammation and altered adipokine secretion, all known to be involved in the 
development of insulin resistance and obesity (18). As it has been described that cell 
size and/or lipid droplet locularity influence cortical actin structures that mediate 
GLUT4 translocation (21), we hypothesize that low Dlk1 and related adipocyte 
hypertrophy could directly influence the development of  insulin resistance. 
Dlk1 is known to be a crucial regulator of the myogenic program in skeletal muscle, 
and it has been shown that Dlk1 has a dual biological function in this tissue, both as an 
enhancer of muscle development and as an inhibitor of adult muscle regeneration 
(22). The observed low Dlk1 expression in skeletal muscle could be involved in 
restraining of muscle development as we observed histologically lower number of 
myofibers per area (myofiber density) in skeletal muscle of R/C pups at P42. In this 
sense, catch-up growth towards fat mass accumulation in detriment of muscular mass 
has been described in humans (23). Low birth weight following free access to food 
during the growing-finishing period in pigs also showed enlarged cross-sectional 
myofiber areas due to enhanced fat deposition (24). Moreover, fat mass accumulation 
in detriment of muscular mass has been related to insulin resistance and 
overexpression of insulin receptor in skeletal muscle in experimental animals (25). In 
our model we observed decreased Dlk1 expression in skeletal muscle in R/C pups that 
was related to increased HOMA-IR values. We therefore suggest that Dlk1 expression 
in skeletal muscle is contributing to the development of insulin resistance during 
catch-up growth. It is tempting to speculate that lower Dlk1 gene expression could 
enhance C/EBPα, a known downstream Dlk1 target molecule, which in turn would 
regulate GLUT4 and affect glucose homeostasis (26). Then, Dlk1 dysregulation would 
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be among the mechanisms explaining why skeletal muscle presents lower insulin-
stimulated glucose utilization and develops insulin resistance during catch-up growth. 
We acknowledge some limitations in our study. Major differences were observed 
between R/C and R/R pups, with fewer differences being evident between R/C and C/C 
pups. It should be highlighted, however, that there were strong linear differences 
between the 3 groups of pups in most of the examined parameters, which give 
relevance to our results. In future studies, our goal will be to examine more severe fat 
mass accumulation or obesity phenotypes during catch-up growth as well as to extend 
the growth period since P42 may have been rather a short juvenile time-point to 
examine the association between Dlk1 and metabolic risk markers. Interestingly 
though, our findings indicate that these metabolic abnormalities take place at an early 
age following catch-up growth. Future studies assessing these parameters for a longer 
period should take into account the age-related sex dimorphism in insulin sensitivity 
that is evident starting at PD90 (3 months), and which has not been described in early 
stages, such as at PD26 or PD40, when the juvenile rats are still not sexually mature 
(27) (28) (29). Finally, we could not analyze the direction of causality of the molecular 
changes observed at PD42 in pups experiencing catch-up growth since the Wistar rat 
model of intrauterine growth restriction induced by calorie restriction throughout 
gestation used in the present study did not include tissues at birth: a few pups were 
removed to equal litter sizes within groups but they were insufficient in number to 
provide tissue samples at birth. Despite these limitations, we have observed novel  
molecular changes in Dlk1 gene expression during catch-up growth.  
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In conclusion, decreased gene expression of Dlk1 in adipose tissue and skeletal muscle 
may contribute to visceral fat expansion and development of insulin resistance during 
catch-up growth following fetal growth restriction. It is tempting to speculate that 
future intervention strategies based on Dlk1 activation may improve the outcome of 
catch-up growth following prenatal growth restriction.  
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Figure  1. Correlation graphs between Dlk1 expression in adipose and skeletal muscle 
tissues and studied parameters in a Wistar rat catch-up growth model. Correlation 
graphs of different R/R, C/C and R/C groups between Dlk1 relative expression in 
retroperitoneal adipose tissue (AT) and (a) body weight at PD42, (b) postnatal body 
weight gain and (c) visceral fat; as well as Dlk1 relative expression in skeletal muscle 
and (d) insulin and (e) HOMA-IR values. Spearman r and p values are shown, P value 
was set at p<0.05 and significant correlations are marked in bold style. Gene 
expression variables have been logarithmically transformed (log10). R/R: restricted, 
C/C: control, R/C: catch-up growth. 
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Figure 2. Adipose tissue and skeletal muscle morphometric parameters in a Wistar 
rat catch-up growth model. Representative images of (a) retroperitoneal adipose 
tissue and (c) skeletal muscle at PD42 are shown (scale bar: 50um). Bar graphs showing 
(b) adipocyte area and adipocyte density (more than 250 adipocytes per group were 
measured), (d) myofibers area and myofiber density (more than 20 fields per group 





























Table 1.  Somatometric, metabolic and gene expression characteristics of the studied 
groups according to pre and postnatal growth: restricted pups (R/R), control pups 
(C/C) and catch-up growth pups (R/C).  
 
 R/R C/C R/C   
Somatometric parameters N=14 N=14 N=14 p p for trend 
Body weight PD1 g 5.10 ± 0.23 * 6.47 ± 0.29 5.08 ± 0.28 * <0.0001 0.912 
Body weight PD22 g 17.81 ± 1.13 43.08 ± 3.56  # 51.32 ± 3.94  # * <0.0001 <0.0001 
Body weight PD42 g 79.43 ± 11.64 170.62 ± 20.37  # 179.42 ± 20.43  # <0.0001 <0.0001 
Postnatal body weight gain g 74.33 ± 11.69 164.15 ± 20.28  # 173.62 ± 20.66  # <0.0001 <0.0001 
Postnatal body weight gain %  14.62 ± 2.54 25.36 ± 3.04  # 33.87 ± 4.17 # * <0.0001 <0.0001 
Retroperitoneal AT g 0.22 ± 0.06 0.75 ± 0.26  # 1.02 ± 0.33 # * <0.0001 <0.0001 
Mesenteric AT g 0.17 ± 0.04 0.35 ± 0.07  # 0.41 ± 0.09  # <0.0001 <0.0001 
Visceral fat g 0.67 ± 0.16 2.12 ± 0.60  # 2.71 ± 0.87 # * <0.0001 <0.0001 
Metabolic parameters N=14 N=14 N=14 p p for trend 
Total adiponectin mg/g 19.81 ± 9.33 12.41 ± 4.71 # 10.42 ± 5.65  # 0.002 0.001 
Glucose mmol/L 8.28 ± 0.74 10.15 ± 0.90  # 9.04 ± 0.56 # * <0.0001 0.011 
Insulin pmol/L 159.1 ± 73.6 267.2 ± 24.6  # 360.1 ± 26.8 # * <0.0001 <0.0001 
HOMA-IR 1.62 ± 0.77 3.53 ± 0.67  # 3.97 ± 1.34 # <0.0001 <0.0001 
Total cholesterol mmol/L 2.47 ± 0.36 2.31 ± 0.16 2.34 ± 0.42 0.448 0.318 
HDL cholesterol mmol/L 0.91 ± 0.19 0.80 ± 0.09 0.89 ± 0.17 0.211 0.787 
Triglycerides mmol/L 0.82 ± 0.27 1.41 ± 0.40  # 1.38 ± 0.58  # 0.001 0.002 
Gene expression N=14 N=14 N=14 p p for trend 
Retroperitoneal adipose 
tissue 
     
Dlk1 relative expression 2-ACt 0.93 ± 0.93 0.02 ± 0.02 # 0.01 ± 0.01# <0.0001 <0.0001 
Dlk1 protein ng/g 392.3 ± 169.5 209.3 ± 148.2 # 82.3 ± 46.1 * # <0.0001 <0.0001 
Skeletal muscle      
Dlk1 relative expression 2-ACt 1.87 ± 1.55 0.39 ± 0.24 # 0.30 ± 0.28# <0.0001 <0.0001 
Values are expressed in mean ± deviation score. R/R: restricted, C/C: control , R/C: catch -up growth, PD: postnatal 
day; AT: adipose tissue, HOMA-IR: homeostatic model  assessment of insulin resistance, HDL: high-density 
lipoprotein. Postnatal  body weight gain percentage in relation to birth body gain, specific adipose tissue weights 
percentage in relation to total  body weight and total  adiponectin was  corrected for body weight. Anova  p and p for 
trend values  are shown (LSD post-hoc tests  are shown with *p<0.05 compared to C/C and # p<0.05 compared to 
R/R). 
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Figure 1. Correlation graphs between Dlk1 expression in adipose and skeletal muscle tissues and studied 
parameters in a Wistar rat catch-up growth model. Correlation graphs of different R/R, C/C and R/C groups 
between Dlk1 relative expression in retroperitoneal adipose tissue (AT) and (a) body weight at PD42, (b) 
postnatal body weight gain and (c) visceral fat; as well as Dlk1 relative expression in skeletal muscle and 
(d) insulin and (e) HOMA-IR values. Spearman r and p values are shown, p value was set at p<0.05 and 
significant correlations are marked in bold style. Gene expression variables have been logarithmically 
transformed (log10). R/R: restricted, C/C: control, R/C: catch-up growth. 
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Figure 2. Adipose tissue and skeletal muscle morphometric parameters in a Wistar rat catch-up growth 
model. Representative images of (a) retroperitoneal adipose tissue and (c) skeletal muscle at PD42 are 
shown (scale bar: 50um). Bar graphs showing (b) adipocyte area and adipocyte density (more than 250 
adipocytes per group were measured), (d) myofibers area and myofiber density (more than 20 fields per 
group were measured) are shown (*p<0.05 compared to C/C and # p<0.05 compared to R/R). 
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